Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002836
Filing Date
2008-03-17
Accepted
2008-03-14 18:23:16
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183700z10-k.htm 10-K 1158951
2 EXHIBIT 3.1 a2183700zex-3_1.htm EX-3.1 53028
3 EXHIBIT 10.21 a2183700zex-10_21.htm EX-10.21 17816
4 EXHIBIT 23.1 a2183700zex-23_1.htm EX-23.1 2747
5 EXHIBIT 31.1 a2183700zex-31_1.htm EX-31.1 6643
6 EXHIBIT 31.2 a2183700zex-31_2.htm EX-31.2 6635
7 EXHIBIT 32.1 a2183700zex-32_1.htm EX-32.1 5274
8 G989424.JPG g989424.jpg GRAPHIC 16100
  Complete submission text file 0001047469-08-002836.txt   1274805
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 (510) 585-2200
ARYx Therapeutics, Inc. (Filer) CIK: 0001410064 (see all company filings)

EIN.: 770456039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33782 | Film No.: 08690746
SIC: 2834 Pharmaceutical Preparations